NASDAQ:MRSN
Delisted

Mersana Therapeutics Stock Forecast

etoro logo Buy MRSN
*Your capital is at risk
$29.08
+0 (+0%)
At Close: Apr 02, 2026

MRSN Performance

FAQ

What is the symbol for Mersana Therapeutics, Inc. Stock and on which exchange is it traded?
The symbol for Mersana Therapeutics, Inc. is MRSN and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Mersana Therapeutics, Inc. Stock?
Based on market data through Apr 02, 2026, StockInvest.us rates Mersana Therapeutics, Inc. (MRSN) as Hold/Accumulate with a technical score of 0.00 on its -10 to +10 scale. The rating is unchanged from the previous daily evaluation. Since the Hold signal began on Nov 14, 2025, the price has risen 4.15%. The current 3-month trend forecast projects flat movement.

How to buy Mersana Therapeutics, Inc. Stock?
Mersana Therapeutics, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Mersana Therapeutics, Inc. Stock.

What's the current price of Mersana Therapeutics, Inc. Stock?
As of the end of day on the Apr 02, 2026, the price of an Mersana Therapeutics, Inc. (MRSN) share was $29.08.

What is the 52-week high and low for Mersana Therapeutics, Inc. Stock?
The 52-week high for Mersana Therapeutics, Inc. Stock is $30.40 and the 52-week low is $0.259.

What is the market capitalization of Mersana Therapeutics, Inc. Stock?
As of the Apr 02, 2026, the market capitalization of Mersana Therapeutics, Inc. is 145.364M.
Click to get the best stock tips daily for free!
ABOUT MERSANA THERAPEUTICS, INC.
Mersana Therapeutics
Mersana Therapeutics, Inc., a clinical stage biopharmaceutical company, develops antibody drug conjugates (ADC) for cancer patients with unmet need. It develops XMT-1592, a Dolasynthen ADC targeting NaPi2b-expressing tumor cells, which is in phase I clinical trial for the treatment of ovarian cancer and NSCLC adenocarcinoma. The company also develops XMT-1660, a B7-H4-targeted Dolasynthen ADC candidate; and XMT-2056, an immunosynthen development ...
GOLDEN STAR
Ticker Change Signal Date
FCX
$62.63
7.46% Jul 31
MC
$67.08
2.40% Jul 31
ARW
$212.85
6.96% Jul 30
BIIB
$202.19
3.10% Jul 24
F
FERG
$230.67
10.77% Jul 24

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE